Fungal cell membrane and cell surface components

The fungal cell membrane and cell surface components constitute a complex of structural and functional elements that are vital for fungal viability and serve as the primary targets for most clinical antifungal therapies. The fungal cell membrane is uniquely characterized by the presence of ergosterol, a sterol that maintains membrane integrity and fluidity, whereas the cell surface is protected by a rigid cell wall composed of chitin, beta-glucans, and mannoproteins (StatPearls, 2023). These components are absent in mammalian cells, providing a basis for selective toxicity. Drugs such as polyenes disrupt the membrane by binding to ergosterol, while azoles and allylamines interfere with ergosterol synthesis, leading to the accumulation of toxic sterol intermediates and membrane dysfunction (NIH, 2022). Echinocandins target the cell wall by inhibiting the synthesis of 1,3-beta-glucan, resulting in osmotic instability and cell lysis (PubMed, 2023). These targets are essential for the treatment of a broad spectrum of fungal infections, including invasive candidiasis, aspergillosis, and various dermatomycoses.

Other names

Fungal cell envelopeFungal cell wall and membraneFungal cell surfaceFungal cell wall componentsFungal membrane components

Antifungal agents targeting these components act through several distinct mechanisms: polyenes (e.g., amphotericin B) bind directly to ergosterol in the cell membrane to form lethal pores; azoles (e.g., fluconazole) and allylamines (e.g., terbinafine) inhibit key enzymes in the ergosterol biosynthetic pathway, such as lanosterol 14-alpha-demethylase and squalene epoxidase, respectively; and echinocandins (e.g., caspofungin) non-competitively inhibit 1,3-beta-glucan synthase, disrupting the synthesis of essential cell wall polysaccharides (StatPearls, 2023; NIH, 2022).